| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 406,2 k € | +16.8% | 347,7 k € | -0.3% | 348,7 k € | +27.5% | 273,5 k € | +37.3% | 199,2 k € | -1.7% | 202,6 k € | -25.2% | 270,7 k € | -9.2% | 298,1 k € | +18.0% | 252,6 k € | +93.9% | 130,3 k € | +20.7% | 107,9 k € | +2.1% | 105,7 k € | +10.7% | 95,5 k € | +63.4% | 58,4 k € | +163.9% | 22,2 k € | |
| EBITDA | 264,9 k € | +28.3% | 206,4 k € | -3.6% | 214,2 k € | +41.1% | 151,8 k € | +70.4% | 89,1 k € | -34.7% | 136,4 k € | -27.5% | 188,1 k € | -9.6% | 208,2 k € | +27.7% | 163,0 k € | +175.6% | 59,1 k € | +35.8% | 43,6 k € | +13.1% | 38,5 k € | -21.4% | 49,0 k € | +95.4% | 25,1 k € | +24.9% | 20,1 k € | |
| Operating profit | 204,9 k € | +38.7% | 147,7 k € | -5.7% | 156,6 k € | +69.0% | 92,6 k € | +200.3% | 30,9 k € | -57.8% | 73,1 k € | -33.7% | 110,2 k € | -16.9% | 132,6 k € | +8.1% | 122,6 k € | +287.7% | 31,6 k € | +46.0% | 21,7 k € | +3.6% | 20,9 k € | -34.8% | 32,1 k € | +91.2% | 16,8 k € | +66.6% | 10,1 k € | |
| Profit/loss | 131,0 k € | +40.9% | 93,0 k € | -9.0% | 102,1 k € | +70.0% | 60,1 k € | +257.3% | 16,8 k € | -69.3% | 54,7 k € | -27.2% | 75,2 k € | -10.7% | 84,2 k € | +13.1% | 74,4 k € | +385.9% | 15,3 k € | +160.1% | 5,9 k € | -43.5% | 10,4 k € | -41.8% | 17,9 k € | +127.8% | 7,9 k € | +138.6% | 3,3 k € | |
| Equity | 512,1 k € | +34.4% | 381,1 k € | +4.9% | 363,3 k € | -12.8% | 416,4 k € | +16.9% | 356,4 k € | -4.0% | 371,2 k € | +17.3% | 316,5 k € | +31.1% | 241,4 k € | +53.6% | 157,2 k € | +90.0% | 82,7 k € | +22.7% | 67,4 k € | +9.6% | 61,5 k € | +20.4% | 51,1 k € | +54.0% | 33,2 k € | +31.1% | 25,3 k € | |
| Total assets | 987,0 k € | +9.6% | 900,6 k € | -0.7% | 906,5 k € | +1.5% | 892,9 k € | -3.7% | 927,7 k € | -13.1% | 1,1 M € | +40.1% | 762,1 k € | +41.9% | 537,2 k € | +74.3% | 308,1 k € | +47.2% | 209,3 k € | +33.3% | 157,0 k € | -2.9% | 161,6 k € | +3.8% | 155,7 k € | +28.4% | 121,3 k € | +4.6% | 115,9 k € | |
| Cash | 273,4 k € | +81.6% | 150,6 k € | +27.5% | 118,1 k € | +39.8% | 84,5 k € | -40.0% | 140,8 k € | -57.8% | 333,9 k € | +72.1% | 194,0 k € | +58.5% | 122,4 k € | +7.2% | 114,2 k € | +199.8% | 38,1 k € | +22.9% | 31,0 k € | -16.7% | 37,2 k € | +0.1% | 37,2 k € | +33.0% | 28,0 k € | +141.6% | 11,6 k € | |
| Debts | 464,7 k € | -9.7% | 514,6 k € | -4.0% | 535,9 k € | +14.9% | 466,3 k € | -17.2% | 563,4 k € | -18.4% | 690,5 k € | +56.1% | 442,4 k € | +50.0% | 294,9 k € | +96.6% | 150,0 k € | +18.5% | 126,6 k € | +41.3% | 89,6 k € | -10.5% | 100,1 k € | -4.3% | 104,6 k € | +18.7% | 88,1 k € | -2.7% | 90,6 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 2 | 2 | 1,9 | 1,8 | 0,3 | |||||||||||||||
Private limited company · Affligem · incorporated on 25/08/2010
Private limited company profitable and well capitalised. Cash position rising (+81.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DENTAAL LABO GHYSENS is a Private limited company incorporated in 2010. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Affligem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette